Cha University

This study looked at tumor and blood samples from 166 people with advanced liver cancer to find genetic markers that might predict how well they respond to treatment. The goal was to better understand the disease and identify new targets for therapy. Participants had already rece…

This study looked at 131 people with advanced liver cancer to see how a combination of two drugs (atezolizumab and bevacizumab) affects tumors in different parts of the body. The goal was to understand why some tumors shrink and others don't, especially in the liver. Researchers …